SCHEMBL3262160

SCHEMBL3262160

Cc1ccccc1-n1nc(C)c(-c2ccc3nc(N)nn3c2)c1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 9/20 0.43
NPC1 O15118 8/20 0.43
RAB9A P51151 8/20 0.43
MAPT P10636 9/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.40
POLB P06746 1/20 0.40
PIK3CG P48736 4/20 0.39
PIK3CD O00329 3/20 0.39
PIK3CA P42336 2/20 0.39
PIK3CB P42338 1/20 0.39
NPSR1 Q6W5P4 3/20 0.38
TP53 P04637 3/20 0.38
NFKB1 P19838 3/20 0.38
NFKB2 Q00653 3/20 0.38
RELA Q04206 3/20 0.38
GLA P06280 2/20 0.38
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3262157 0.88 ALDH1A1 (0.40) HTTKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL7937768 0.76 ADORA1 (0.53) LRRK2
SCHEMBL3974032 0.76 SMN1; SMN2 (0.54) HTTKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL3305577 0.71 ADORA1 (0.58) HTTKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL614711 0.70 RET (0.61) ALDH1A1PIK3CGPIK3CDPIK3CAPIK3CB
SCHEMBL2186588 0.67 PIK3CG (0.60) PIK3CGPIK3CDPIK3CAPIK3CBLRRK2
SCHEMBL936441 0.66 PIK3CG (0.51) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL1819331 0.66 HTT (0.60) HTTKMT2ASMN1; SMN2NPC1RAB9A
SCHEMBL1933137 0.65 PIK3CG (0.52) KMT2ASMN1; SMN2NPC1RAB9AMAPT
SCHEMBL6181854 0.65 HTT (0.47) HTTKMT2AMAPTALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010020363-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-25 WO disclosed